Clearside Biomedical
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $90 | $230 | $6,345 | $859 |
Gross Profit | 46 | 202 | 6,325 | 717 |
EBITDA | -7,546 | -8,180 | -2,895 | -7,054 |
EBIT | -7,590 | -8,208 | -2,915 | -7,070 |
Net Income | -7,594 | -11,763 | -4,832 | -9,267 |
Net Change In Cash | 90 | 230 | 6,345 | 859 |
Free Cash Flow | -6,103 | -7,908 | 375 | -6,520 |
Cash | 18,238 | 35,355 | 28,920 | 28,802 |
Basic Shares | 74,731 | 69,853 | 62,404 | 61,983 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $8,226 | $1,327 | $29,575 | $7,894 |
Gross Profit | 7,804 | 1,123 | 29,397 | 7,894 |
EBITDA | -24,777 | -29,608 | -449 | -17,755 |
EBIT | -24,844 | -29,753 | -627 | -17,935 |
Net Income | -32,485 | -34,071 | 376 | -18,030 |
Net Change In Cash | 8,226 | 1,327 | 29,575 | 7,894 |
Cost of Revenue | 17,722 | 13,049 | -5,308 | |
Free Cash Flow | -19,912 | -13,611 | -10,733 | -13,175 |
Cash | 28,920 | 48,258 | 30,436 | 17,287 |
Basic Shares | 61,806 | 60,204 | 59,906 | 46,506 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.10 |
2024-03-31 | -$0.15 |
2023-12-31 | -$0.08 |
2023-09-30 | -$0.15 |
